Viewing data from:

DIPYRIDAMOLE

ANDA

DIPYRIDAMOLE | A040542 | OXFORD PHARMACEUTICALS LLC

3 strengths0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Dipyridamole (2023)

Total Spending

$1.8M

Total Claims

13,865

Beneficiaries

3,216

Avg Cost/Unit

$1.00

Spending Trend

$2.5M(2019)→$3.2M(2020)→$3.1M(2021)→$2.4M(2022)→$1.8M(2023)

YoY Change:-10.9%

5yr CAGR:+10.1%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain8 active DMFs10 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRLDIPYRIDAMOLE

DMF 32091978

AGC PHARMA CHEMICALS EUROPE SLUDIPYRIDAMOLE

DMF 138701998

ORCHID PHARMA LTDDIPYRIDAMOLE

DMF 204162007

MATRIX PHARMACORP PRIVATE LTDDIPYRIDAMOLE USP

DMF 244412010

ALIVUS LIFE SCIENCES LTDDIPYRIDAMOLE USP

DMF 290202015

COHANCE LIFESCIENCES LTDDIPYRIDAMOLE USP

DMF 297452015

QIDONG DONGYUE PHARMACEUTICAL CO LTDDIPYRIDAMOLE

DMF 349952020

SOLARA ACTIVE PHARMA SCIENCES LTDDIPYRIDAMOLE USP

DMF 350452020

ERREGIERRE SPAInactiveDIPYRIDAMOLE

DMF 34891979

INDUSTRIE CHIMICHE FARMACEUTICHE ITALIANE SPAInactiveDIPYRIDAMOLE

DMF 35591979

SA AJINOMOTO OMNICHEM NVInactiveDIPYRIDAMOLE

DMF 38671980

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAInactiveDIPYRIDAMOLE

DMF 40161980

SHANGHAI NO 6 PHARMACEUTICAL FACTORYInactiveDIPYRIDAMOLE

DMF 59171985

MEDICHEM SAInactiveDIPYRIDAMOLE

DMF 63171986

LISAC SAInactiveDIPYRIDAMOLE

DMF 79051989

OMNICHEM NVInactiveDIPYRIDAMOLE USP

DMF 148862000

BOEHRINGER INGELHEIM LABSO CHIMIE FINEInactiveDIPYRIDAMOLE

DMF 227642009

YABAO PHARMACEUTICAL GROUP CO LTDInactiveDIPYRIDAMOLE USP

DMF 285662014

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 21, 2006

No patent or exclusivity listings for this strength.

#002 — 50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 21, 2006

#003 — 75MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 21, 2006